The mood stabilizers lithium and valproate disrupt hepatic and intestinal farnesoid X receptor signalling and increase bile synthesis in the rat
Experimental Physiology · 2025
DOI: 10.1113/ep092451 ↗At a glance
Journal article in Experimental Physiology, 2025. Written by Sofia Cussotto and 10 co-authors. Institution: APC Microbiome Ireland, University College Cork, Cork, Ireland. Major MEDLINE topics: Valproic Acid, Receptors, Cytoplasmic and Nuclear, Liver, Bile Acids and Salts. Cited 1 times so far (Crossref); 113 references. The full text is freely available (open access, CC BY 4.0). Funded by: Science Foundation Ireland.
Abstract (original language)
The mood stabilizers lithium and valproate are psychotropic medications widely used in clinical practice. Despite their proven benefits, many individuals stop their treatment due to the adverse effects. Chronic diarrhoea is a common reason for discontinuation of these drugs; however, the underlying mechanisms are unknown. Excessive loss of bile acids (BA) into the colon is a major cause of diarrhoea. Therefore, we aimed to investigate the effects of these drugs on BA metabolism. We measured BA levels in the liver, plasma and faeces of Sprague–Dawley rats treated with lithium or valproate for 4 weeks. Next, we analysed changes in the expression of genes and proteins involved in BA production and enterohepatic circulation. Lithium and valproate markedly increased BA levels across all body sites. This was accompanied by the up‐regulation of hepatic cytochrome P450 7A1 (Cyp7a1), the rate‐limiting enzyme in de novo BA synthesis. Under normal conditions, elevated levels of BAs suppress Cyp7a1 via activation of the hepatic farnesoid X receptor (Fxr)/small heterodimer partner (Shp) and intestinal Fxr/fibroblast growth factor 19 (Fgf19) pathways. This signalling was disrupted in both treatment groups. The Fxr‐mediated responses in the expression of Ntcp, Asbt, Ilbp and Ostα/β bile transporters were also affected by treatment. In conclusion, lithium and valproate disrupted farnesoid X receptor signalling at the hepatic and intestinal levels, inducing sustained overproduction of bile in rats. These findings provide novel insights into the peripheral effects of these drugs. Given that similar changes in bile circuits underlie the pathophysiology of primary BA diarrhoea in humans, this study suggests a potential mechanism behind chronic diarrhoea in patients undergoing lithium or valproate therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- APC Microbiome Ireland, University College Cork, Cork, Ireland.
- Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland.
- School of Biochemistry and Cell Biology, University College Cork, Cork, Ireland.
- School of Pharmacy, University College Cork, Cork, Ireland.
- Mass Spectrometry Core, UCD Conway Institute, Dublin, Ireland.
- INFANT research centre, CUH, Cork, Ireland.
ORCID profiles: Susan A Joyce, John F Cryan
Funding
- Science Foundation Ireland
Cite
APA
Cussotto, S., Golubeva, A. V., Gallardo, A. L., Bastiaanssen, T. F. S., Zhdanov, A. V., Moloney, G. M., Scaife, C., English, J. A., Joyce, S. A., Dinan, T. G., & Cryan, J. F. (2025). The mood stabilizers lithium and valproate disrupt hepatic and intestinal farnesoid X receptor signalling and increase bile synthesis in the rat. Experimental Physiology. https://doi.org/10.1113/ep092451
Vancouver
Cussotto S, Golubeva AV, Gallardo AL, Bastiaanssen TFS, Zhdanov AV, Moloney GM, et al. The mood stabilizers lithium and valproate disrupt hepatic and intestinal farnesoid X receptor signalling and increase bile synthesis in the rat. Experimental Physiology. 2025. doi:10.1113/ep092451
BibTeX
@article{Cussotto2025,
author = {Cussotto, Sofia and Golubeva, Anna V and Gallardo, Alvaro Lopez and Bastiaanssen, Thomaz F S and Zhdanov, Alexander V and Moloney, Gerard M and Scaife, Caitriona and English, Jane A and Joyce, Susan A and Dinan, Timothy G and Cryan, John F},
title = {The mood stabilizers lithium and valproate disrupt hepatic and intestinal farnesoid X receptor signalling and increase bile synthesis in the rat},
journal = {Experimental Physiology},
year = {2025},
doi = {10.1113/ep092451}
}
EUVIMED